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Background: Seroma formation is a frequent complication following radical lymph node dissection (RLND) in
patients with metastatic melanoma. Several strategies have been used to prevent fluid accumulation and thereby
reduce the duration of postoperative drainage, including fibrin sealants.
Methods: This was a prospective, single-center study in which consecutive patients undergoing surgical treatment
of stage III metastatic melanoma by axillary or ilio-inguinal RLND were randomized to receive standard treatment
plus fibrinogen/thrombin-coated collagen sealant patch (CSP) or standard treatment alone. The primary endpoint of
the study was postoperative duration of drainage.
Results: A total of 70 patients underwent axillary (n = 47) or ilio-inguinal (n = 23) RLND and received CSP plus
standard treatment (n = 37) or standard treatment alone (n = 33). Mean duration of drainage was significantly
reduced in the CSP group compared with standard treatment (ITT analysis: 20.1 ± 5.1 versus 23.3 ± 5.1 days; p = 0.010).
The percentage of patients drainage-free on day 21 was significantly higher in the CSP group compared with the
standard treatment group (86% versus 67%; p = 0.049).
Conclusions: Use of the tissue sealant resulted in a significant reduction in duration of drainage. Further studies are
warranted to confirm these results in different and selected types of lymphadenectomy.
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Radical lymph node dissection (RLND) is generally pro-
posed as the only treatment for local control of node-
positive stage III melanoma patients. However, ilio-
inguinal and axillary dissections have been associated
with a number of postoperative complications, ranging
from wound infections to skin flap necrosis. These can
result in increased hospital costs, reduced quality of life
of patients and a delayed return to work and other activ-
ities. The incidence of complications after ilio-inguinal
and axillary lymphadenectomy varies greatly. In previous
studies, axillary RLND in patients with melanoma
resulted in a local complication rate of between 25% and
48%, with over half of the observed complications being
delayed wound healing secondary to serum collection
[1,2]. Similarly, postoperative complications related to* Correspondence: gidimonta@libero.it
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reproduction in any medium, provided the orseroma formation occurred in 32% to 80% of patients
after ilio-inguinal RLND [3,4].
Intraoperative insertion of closed suction drains at the
time of RLND is the traditional method used to reduce
seroma formation and subsequent wound complications.
However, closed suction drains require ongoing surveil-
lance and maintenance, restrict patients’ physical activity
and delay their return to normal life. They can also be
associated with complications such as infection or flap
necrosis. Consequently, effective strategies to reduce the
incidence of seroma formation and thereby allow earlier
drain removal offer benefits to both patients and
surgeons.
A variety of different methods to reduce seroma for-
mation have been previously proposed, all of which aim
to reduce dead space and seal leaking capillaries and
lymphatic channels. These approaches include closing
dead space by tacking sutures [5], delayed exercise [6,7],
spraying tetracycline [8], using ultrasound cutting
devices [9], applying bovine thrombin during surgeryral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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proach has been proposed to provide sealing and tissue
apposition in a large number of surgical procedures, es-
pecially after surgery for breast cancer, although results
have been mixed [4,13-16].
One strategy may be the use of a fixed combination of
collagen matrix-bound coagulation factors. TachoSilW
(Nycomed, Takeda Pharmaceuticals International GmbH,
Zurich, Switzerland) is a tissue sealant consisting of an
equine collagen sealant patch (CSP) coated with human
fibrinogen and thrombin. It is ready to use, and differs
from other sealing agents in being a fixed patch that is
activated by the operated surface after 3 to 5 minutes of
compression [17]. The efficacy and safety of CSP has
been shown in several different surgical fields including
hemostasis and bile sealing in liver surgery [18,19], air
sealing in pulmonary lobectomy [20-22], and hemostasis
in kidney tumor resection [23], cardiovascular and vas-
cular surgery [24,25]. CSP is approved worldwide and is
indicated in adults for supportive treatment in surgery
for improvement of hemostasis, to promote tissue sealing,
and for suture support in vascular surgery where stand-
ard techniques are insufficient.
In this study, the use of CSP to decrease seroma for-
mation and reduce the time to closed suction drain re-
moval was investigated in patients with metastatic
melanoma undergoing RLND.
Methods
This was a prospective study carried out at a single cen-
ter in which consecutive patients were randomized to
receive standard treatment plus CSP or standard treat-
ment alone. The study was conducted according to the
Declaration of Helsinki and in accordance with Good
Clinical Practice. All patients provided written informed
consent.
Patients were eligible for the study if they were candi-
dates for surgical treatment of metastatic melanoma
stage III by axillary or ilio-inguinal RLND. Previous radi-
ation therapy at the operative site was an exclusion cri-
terion. Patients were also excluded if they were obese
with a body mass index (BMI) > 30 kg/m2, were preg-
nant or lactating, had received steroids within the past 6
months, or had a severe pre-existing concomitant med-
ical condition. Randomization was achieved by drawing
lots.
Surgical technique
All surgery was performed by the Head of Department
or by a senior member of his team. Axillary dissection
was carried out through a transverse/S-shaped incision,
raising 1 cm thick skin flaps by electrocautery to the lat-
eral border of the pectoralis major and latissimus dorsi
muscles. RLND was realized on level I, II and III, en blocwith the pectoralis minor muscle and supra-axillary fat
pad, preserving the thoracodorsal neurovascular bundle
and the long thoracic nerve. Major vessels, but not
lymphatic vessels, were ligated, while fat dissection was
carried out by electrocautery. At the end of surgery, a
closed suction drain was inserted through the inferior
skin flap and into the axilla.
Inguinal RLND was initiated with a lazy S incision
extending from the anterior superior iliac spine to the
apex of the femoral triangle. Skin flaps were raised using
electrocautery medially to the pubic tubercle and to
the adductor longus muscle, and laterally to the apex
of the femoral triangle. The fatty, node-bearing tissue
of the triangle was removed, skeletonising the femoral
bundle in a subadventitial plane and transecting the
saphenous vein at the confluence. Access to the iliac
fossa was obtained via a transverse incision through the
external oblique aponeurosis, 4 cm above the inguinal
ligament, lifting up the peritoneum. RLND was per-
formed around the external iliac vessels up to the level
of the ureter and down in the pelvis to the obturator
nerve. Finally, the muscular and aponeurosis edges were
sutured, and the wound closed over a closed suction
drain in the femoral triangle.
In the CSP group, the patches were applied subcutane-
ously to cover the whole surgical bed before closure after
RLND.
Postoperative care
All patients were instructed to reduce physical activity
for the first week, to shower regularly, to record daily
drainage volume and to return to the hospital for weekly
follow-up visits to a dedicated outpatient nurse team,
blinded to the received treatment. Drainage was
removed when the 24-hour drainage volume had
decreased to less than 50 cc for two consecutive days (in
which case patients were instructed to return to the hos-
pital the following day) or 30 days after surgery.
Statistical analysis
The primary endpoint of the study was post-operative
duration of drainage. Secondary endpoints were drainage
removal incidence and daily drainage volume on post-
operative days 3, 10, 15 and 21. Intention-to-treat (ITT)
analysis was used for all endpoints. Per-protocol (PP)
analysis was also conducted for the primary endpoint.
All statistical analyses were carried out with the SASW
software package (SAS, Version 9.2, SAS Institute Inc.,
Cary NC, USA). P-values were considered significant if <
0.05. Categorical variables were compared using the chi
square or Fisher exact test when appropriate. Continu-
ous variables were compared using the unpaired t-test
or the non-parametric Wilcoxon’s independent sample
test according to whether or not the data distribution
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The probability of drainage removal was also assessed
using Kaplan-Meier curves and a log-rank test used to
compare groups.
Results
Between July 2009 and November 2010, 70 patients with
melanoma underwent an axillary or ilio-inguinal RLND
and were included in the study. Of these patients, 47
had axillary metastases and 23 had inguinal metastases.
Thirty-seven patients were randomized to the standard
treatment plus CSP group (axillary metastases, n = 26;
inguinal metastases, n = 11) and 33 were randomized
to the control group receiving standard treatment only
(axillary metastases, n = 21; inguinal metastases, n = 12).
In the group with axillary disease treated with CSP,
6/26 patients (23%) underwent dissection after sentinel
node biopsy (SNB), while in the standard treatment
group 6/21 (28%) underwent dissection for clinical dis-
ease. In the group with groin disease treated with CSP,
1/11 patients (9.1%) were submitted to dissection after
SNB, while 2/12 (16.6%) in the standard treatment
group were submitted to dissection for clinical disease.
Surgical procedures after positive SNB and after palpable
disease were identical.
All 70 patients were included in the ITT analysis. Two
patients in the standard care group had their drains
removed because of complications (dehiscence) and so
were excluded from the PP analysis.
The two treatment groups were comparable with re-
gard to age, sex, number of removed lymph nodes and
number of positive lymph nodes (Table 1). The median
age of the patients was 59 years (range 29 to 82) in the
CSP group and 64 years (26 to 84) in the standard treat-
ment group (P = 0.65). The median number of lymph
nodes removed was 20 (14 to 33) in the CSP group and
19 (10 to 34) in the standard treatment group. In the
TachoSilW group, the median number of positive lymph
nodes was 2 (0 to 13) while in the standard treatment
group it was 1 (0 to 15). These values do not include the
sentinel lymph node, which was surgically removed in
all patients.Table 1 Patient characteristics
TachoSilW (n = 37)
Sex, female/male 15/22
Age, years* 59 (29, 82)
Body mass index, kg/m2* 19.5, 24.3
Lymph nodes positive* 0, 13
Lymph nodes removed* 14, 33
Sentinel node cases, n 7
Clinical disease cases, n 30
*Data given as median and/or (range).Duration of drainage
Duration of drainage is reported in Table 2. In the ITT
population, the mean duration of drainage was signifi-
cantly reduced in the CSP group compared with standard
treatment (20.1 ± 5.1 versus 23.3 ± 5.1 days; P = 0.010).
This significant difference in drainage duration was also
observed in the PP analysis, which excluded two standard
treatment patients (20.1 ± 5.1 days in the CSP group
versus 24.0 ± 4.6 days in the standard treatment group;
P = 0.002). These findings are confirmed by the
Kaplan-Meier analysis, in which drainage removal oc-
curred significantly earlier in the TachoSilW group com-
pared with standard treatment. The result of the log-rank
test for the comparison between the two curves is statis-
tically significant in favor of the CSP group (P = 0.024).Drainage removal incidence
The percentage of patients drainage-free on day 21 was
significantly higher in the CSP group compared with the
standard treatment group (86% versus 67%; P = 0.049)
(Table 3). No statistically significant differences between
groups were detected at the other time points assessed
(days 3, 10 and 15).Drainage volume
Daily drainage volume did not significantly differ between
the CSP group and the standard treatment group on
days 3, 10 or 15, but approached statistical significance
on day 21 (25.7 ± 89.5 versus 39.7 ± 63.9 cc; P = 0.058)
(Table 4).Complications
There were no intraoperative complications in either
group. Two patients in the standard treatment control
group had a dehiscence after ileo-inguinal dissection;
one because of partial skin flap necrosis and one because
of wound infection. No other major postoperative com-
plications occurred and there was no perioperative
mortality.Standard treatment (n = 33) P-value
12/21 0.720






Table 2 Mean ± SD duration of closed suction drain placement in patients treated with TachoSilW versus standard
treatment
TachoSilW (n = 37) Standard treatment (n = 33) P-value
Day of drainage removal (ITT) 20 (5) 23 (5) 0.010
Day of drainage removal (PP) 20 (5) 24 (4) 0.002
ITT intention-to-treat; PP per protocol.
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The most common complication after RLND is fluid col-
lection in the wound. The pathophysiology of seroma
formation is not clearly understood and different hy-
potheses have been proposed, largely based on evidence
from patients undergoing axillary RLND after mastec-
tomy. Woodworth, et al. (2000) suggested that seroma
formation is a consequence of surgical disruption of
lymphatics and capillaries with ensuing leakage of fluid
into the dead space created by surgical dissection [26].
Others have proposed that seroma is a consequence of
inflammatory exudates, showing high concentrations of
proteins in fluid aspirates [27]. Previous studies suggest
that the bulk of the fluid accumulation after RLND is
not simply lymph from divided lymphatic vessels. How-
ever, neither it is merely a collection of serum, but rather
consists of fluid formed by acute inflammatory exudates
in response to surgical trauma and the acute phase of
wound healing [27,28].
Most surgeons use closed suction drainage following
RLND, with the duration of drainage in melanoma
patients differing widely, from 4 to 5 days in one report
[29], to 26 to 31 days in another study [4]. Evidently,
drainage duration largely depends on the surgical prac-
tice and routine of the particular surgeon or center and
the results of individual trials must be considered in this
context.
Postoperative wound drainage has a significant nega-
tive impact on patients’ well-being, interfering with their
normal daily activities, reducing sleep and delaying their
return to work. In a study of melanoma patients who
had undergone inguino-femoral lymph node dissection,
Mortenson and coworkers found that getting dressed,
bathing, and sleeping was a major problem for 67%, 78%
and 72% of patients, respectively [4]. The majority of
these patients were theoretically willing to pay US$100
to US$200 out-of-pocket costs to reduce the time ofTable 3 Cumulative incidence of drainage-free patients (%) tr
postoperative days 3, 10, 15 and 21





Results are presented as percentage of patients who were drainage-free.drain removal by 4 days or more, indicating the signifi-
cant impact drains have on patient’s quality of life [4].
The use of different surgical techniques, including
avoidance of electrocautery, tacking sutures, ultrasound
cutting devices, and modified lines of incision, have
proven largely ineffective in preventing or reducing fluid
collection after RLND [5-9]. The addition of fibrin sea-
lants have also been disappointing in lymphadenectomy
for melanoma [4,29,30]. In one randomized controlled
trial of 30 melanoma patients, fibrin sealant did not de-
crease seroma output or time to drain removal following
ilio-inguino lymph node dissection [4]. In two other ran-
domized studies in which patients with malignant mel-
anoma underwent either axillary (n = 58) or combined
radical ilio-inguinal (n = 58) dissection, the intraopera-
tive application of fibrin sealant did not reduce the dur-
ation of closed suction drainage or length of
postoperative hospital stay [29,30].
Both of these previous studies were comparable to the
present study with regard to number of patients, site of
lymphadenectomy, and number of removed lymph
nodes. However, in the current study the use of the tis-
sue sealant resulted in a reduction in duration of drain-
age of approximately 3 to 4 days compared with
standard treatment alone. Differences of this extent have
previously been reported as meaningful for patients [4].
It is not clear why these results differ from previous
studies of other sealants. However, CSP differs from the
liquid fibrin sealants used in earlier studies, due to the
presence of the collagen fleece which serves as add-
itional layer for sealing. This may be one possible ex-
planation for the benefits observed here. Results shown
in this article are also consistent with those of a similar
randomized prospective pilot trial of CSP to prevent ser-
oma after pelvic lymphadenectomy for urologic malig-
nancies [31]. In this, the use of TachoSilW effectively
reduced drainage volume and prevented lymphoceleeated with TachoSilW versus standard treatment on





Table 4 Mean ± SD daily drainage volume in patients
treated with TachoSilW versus standard treatment on
postoperative days 3, 10, 15 and 21
Postoperative
day
TachoSilW Standard treatment P-value
(n = 37) (n = 33)
Day 3 175.8 ± 95.3 170.0 ± 59.4 0.844
Day 10 143.1 ± 128.1 162.1 ± 86.8 0.096
Day 15 96.1 ± 109.9 104.3 ± 71.5 0.214
Day 21 25.7 ± 89.5 39.7 ± 63.9 0.058
Results are presented as mean drainage volume ± SD (cc).
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prostatectomy for prostate cancer.
Conclusion
Current study findings confirm and support previous
suggestions that TachoSilW is an effective tissue sealant
that can reduce lymphatic leakage following surgery.
Further studies are warranted to confirm these results in
longer series and in different and selected types of
lymphadenectomy.
Competing interests
No conflict of interests to declare. TachoSilW was provided by the hospital
pharmacy free of charge.
Authors’ contributions
NM conceived the study, drafted the manuscript and performed surgical
procedures. GDM helped to draft the manuscript and carried out the
literature research. CC and UM helped surgical procedures and management
of the patients. AC performed statistical analysis. All authors read and
approved the final manuscript.
Author details
1Department of Surgery, “Melanoma, Soft Tissues, Head and Neck, Skin
Cancers”, National Cancer Institute of Naples, Naples 80131, Italy.
2Department of Epidemiology, National Cancer Institute of Naples, Naples
80131, Italy.
Received: 9 October 2012 Accepted: 26 November 2012
Published: 19 December 2012
References
1. Bland KI, Klamer TW, Polk HC Jr, Knutson CO: Isolated regional lymph node
dissection: morbidity, mortality and economic consideration. Ann Surg
1981, 193:372–376.
2. Urist NM, Maddox WA, Kennedy JE, Balch CM: Patients risk factor and
surgical morbidity after regional lymphadenectomy in 204 melanoma
patients. Cancer 1983, 51:2152–2156.
3. Tonouchi H, Ohmori Y, Kobayashi M, Konishi N, Tanaka K, Mohri Y, Mizutani
H, Kusunoki M: Operative morbidity associated with groin dissections.
Surg Today 2004, 34:413–418.
4. Mortenson MM, Xing Y, Weaver S, Lee JE, Gershenwald JE, Lucci A,
Mansfield PF, Ross MI, Cormier JN: Fibrin sealant does not decrease
seroma output or time to drain removal following inguino-femoral node
dissection in melanoma patients: a randomized controlled trial. World J
Surg Oncol 2008, 6:63–70.
5. Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, Saito S:
Effect of mechanical closure of dead space on seroma formation after
breast surgery. Breast Cancer 2006, 13:260–265.
6. Schultz I, Barholm M, Grondal S: Delayed shoulder exercises in reducing
seroma frequency after modified radical mastectomy: a prospective
randomized study. Ann Surg Oncol 1997, 4:293–297.7. Shamley DR, Barker K, Simonite V, Beardshaw A: Delayed versus immediate
exercises following surgery for breast cancer: a systematic review. Breast
Cancer Res Treat 2005, 90:263–271.
8. Rice DC, Morris SM, Sarr MG, Farnell MB, van Heerden JA, Grant CS, Rowland
CM, Ilstrup DM, Donohue JH: Intraoperative topical tetracycline
sclerotherapy following mastectomy: a prospective randomized trial.
J Surg Oncol 2000, 73:224–227.
9. Galatius H, Okholm M, Hoffmann J: Mastectomy using ultrasonic
dissection: effect on seroma formation. Breast 2003, 12:338–341.
10. Burak WE Jr, Goodman PS, Young DC, Farrar WB: Seroma formation
following axillary dissection for breast cancer: risk factors and lack of
influence of bovine thrombin. J Surg Oncol 1997, 64:27–31.
11. Moore M, Burak W, Nelson E, Kearney T, Simmons R, Mayers L, Spotnitz WD:
Fibrin sealant reduces the duration and amount of fluid drainage after
axillary dissection. A randomized prospective clinical trial. J Am Coll Surg
2001, 192:591–599.
12. Mustonen PK, Harma MA, Eskelinen MJ: The effect of fibrin sealant
combined with fibrinolysis inhibitor on reducing the amount of
lymphatic leakage after axillary evacuation in breast cancer. Scand J Surg
2004, 93:209–212.
13. Ulusoy AN, Polat C, Alvur M, Kandemir B, Bulut F: Effect of Fibrin glue on
lymphatic drainage and on drain removal time after modified radical
mastectomy: a prospective randomized study. Breast J 2003, 9:393–396.
14. Langer S, Guenther MJ, Di Fronzo LA: Does fibrin sealant reduce drain
output and allow earlier removal of drainage catheters in women
undergoing operation for breast cancer? The Am Surgeon 2003, 69:77–81.
15. Jain PK, Sowdi R, Anderson AD, MacFie J: Randomized clinical trial
investigating the use of drains and fibrin sealant following surgery for
breast cancer. Br J Surg 2004, 91:54–60.
16. Carless PA, Henry DA: Systematic review and meta-analysis of the use of
fibrin sealant to prevent seroma formation after breast cancer surgery.
Br J Surg 2006, 93:810–819.
17. TachoSil: Summary of product characteristics - date of latest renewal. 2009.
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_
Information/human/000505/WC500032413.pdf.
18. Fischer L, Seiler CM, Broelsch CE, de Hemptinne B, Klempnauer J, Mischinger
HJ, Gassel HJ, Rokkjaer M, Schauer R, Larsen PN, Tetens V, Büchler MW:
Hemostatic efficacy of TachoSil in liver resection compared with argon
beam coagulator treatment: an open, randomized, prospective,
multicenter, parallel-group trial. Surgery 2011, 149:48–55.
19. Toti L, Attia M, Manzia TM, Lenci I, Gunson B, Buckels JA, Mirza DF, Mayer
AD, Bramhall SR, Wigmore SJ: Reduction in bile leaks following adult split
liver transplant using a fibrin-collagen sponge: A pilot study. Dig Liver Dis
2010, 42:205–209.
20. Lang G, Csekeö A, Stamatis G, Lampl L, Hagman L, Marta GM, Mueller MR,
Klepetko W: Efficacy and safety of topical application of human
fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment
of air leakage after standard lobectomy. Eur J Cardiothorac Surg 2004,
25:160–166.
21. Anegg U, Lindenmann J, Matzi V, Smolle J, Maier A, Smolle-Jüttner F:
Efficiency of fleece-bound sealing (TachoSil) of air leaks in lung surgery:
a prospective randomised trial. Eur J Cardiothorac Surg 2007,
31:198–202.
22. Droghetti A, Schiavini A, Muriana P, Folloni A, Picarone M, Bonadiman C,
Sturani C, Paladini R, Muriana G: A prospective randomized trial
comparing completion technique of fissures for lobectomy: stapler
versus precision dissection and sealant. J Thorac Cardiovasc Surg 2008,
136:383–391.
23. Siemer S, Lahme S, Altziebler S, Machtens S, Strohmaier W, Wechsel HW,
Goebell P, Schmeller N, Oberneder R, Stolzenburg JU, Becker H, Lüftenegger
W, Tetens V, Van Poppel H: Efficacy and safety of TachoSil as haemostatic
treatment versus standard suturing in kidney tumor resection: a
randomised prospective study. Eur J Urol 2007, 52:1156–1163.
24. Maisano F, Kjaergård HK, Bauernschmitt R, Pavie A, Rábago G, Laskar M,
Marstein JP, Falk V: TachoSil surgical patch versus conventional
haemostatic fleece material for control of bleeding in cardiovascular
surgery: a randomized controlled trial. Eur J Cardiothorac Surg 2009,
36:708–714.
25. Bajardi G, Pecoraro F, Mirabella D: Efficacy of TachoSil patches in
controlling Dacron suture-hole bleeding after abdominal aortic
aneurysm open repair. J Cardiothorac Surg 2009, 4:60.
Di Monta et al. World Journal of Surgical Oncology 2012, 10:275 Page 6 of 6
http://www.wjso.com/content/10/1/27526. Woodworth P, McBoyle MF, Helmer SD, Beamer RL: Seroma formation after
breast cancer surgery: incidence and predicting factors. Ann Surg 2000,
66:444–452.
27. Mc Caul JA, Aslaam A, Spooner RJ, Louden I, Cavanagh T, Purushotham AD:
Aetiology of seroma formation in patients undergoing surgery for breast
cancer. Breast 2000, 9:144–148.
28. Agrawal A, Ayantunde AA, Cheung KL: Concepts of seroma formation and
prevention in breast cancer surgery. ANZY Surg 2006, 76:1088–1095.
29. Neuss H, Raue W, Koplin G, Schwenk W, Reetz C, Maal JW: A prospective
randomized trial: The influence of intraoperative application of fibrin
glue after radical inguinal/iliacal lymph node dissection on post-
operative morbidity. Eur J Surg Oncol 2009, 35:884–889.
30. Neuss H, Raue W, Koplin G, Schwenk W, Reetz C, Mall JW: Intraoperative
application of fibrin sealant does not reduce the duration of closed
suction drainage following radical axillary lymph node dissection in
melanoma patients: a prospective randomized trial in 58 patients. World
J Surg 2008, 32:1450–1455.
31. Simonato A, Varca V, Esposito M, Venzano F, Carmignani G: The use of a
surgical patch in the prevention of lymphoceles after extraperitoneal
pelvic lymphadenectomy for prostate cancer: a randomized prospective
pilot study. J Urol 2009, 182:2285–2290.
doi:10.1186/1477-7819-10-275
Cite this article as: Di Monta et al.: Collagen sealant patch to reduce
lymphatic drainage after lymph node dissection. World Journal of Surgical
Oncology 2012 10:275.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
